Fig. 2 | Scientific Reports

Fig. 2

From: Investigation of the cytotoxic effects and mechanisms of the SLC39A6-targeting ADC drug BRY812 in CRC

Fig. 2

Biological function of SLC39 A6 within tumor tissues of CRC. (A) Box plots for 2 groups show the comparisons of the expression levels of tumor-associated signaling pathways. (B) KEGG pathway analysis. (C) The Gene Set Variation Analysis (GSVA) was conducted to assess the signaling pathways associated with high-SLC39A6 compared to low-SLC39A6. (D) Representative Gene Set Enrichment Analysis (GSEA) plots.

Back to article page